Janney Montgomery Scott’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.4M Buy
116,856
+14,086
+14% +$7.64M 0.14% 150
2025
Q4
$59.6M Sell
102,770
-255
-0.2% -$144K 0.14% 155
2025
Q3
$50M Sell
103,025
-395
-0.4% -$184K 0.12% 173
2025
Q2
$41.9M Sell
103,420
-19,013
-16% -$7.95M 0.11% 192
2025
Q1
$60.9M Sell
122,433
-9,505
-7% -$5.15M 0.17% 124
2024
Q4
$68.6M Sell
131,938
-5,101
-4% -$2.8M 0.19% 106
2024
Q3
$84.8M Sell
137,039
-3,811
-3% -$2.26M 0.24% 84
2024
Q2
$77.9M Sell
140,850
-1,989
-1% -$1.14M 0.24% 86
2024
Q1
$83M Sell
142,839
-6,339
-4% -$3.56M 0.25% 84
2023
Q4
$79.2M Sell
149,178
-4,351
-3% -$2.11M 0.26% 78
2023
Q3
$77.7M Sell
153,529
-43,593
-22% -$23.2M 0.29% 70
2023
Q2
$103M Buy
197,122
+3,031
+2% +$1.64M 0.36% 62
2023
Q1
$112M Sell
194,091
-12,680
-6% -$7.15M 0.46% 48
2022
Q4
$114M Buy
206,771
+2,104
+1% +$1.11M 0.44% 44
2022
Q3
$104M Buy
204,667
+7,836
+4% +$4.39M 0.44% 41
2022
Q2
$106M Buy
196,831
+15,515
+9% +$8.54M 0.48% 40
2022
Q1
$107M Buy
181,316
+470
+0.3% +$270K 0.46% 46
2021
Q4
$121M Buy
180,846
+3,807
+2% +$2.38M 0.47% 46
2021
Q3
$101M Buy
177,039
+4,768
+3% +$2.62M 0.43% 52
2021
Q2
$86.9M Sell
172,271
-720
-0.4% -$340K 0.38% 63
2021
Q1
$79M Buy
172,991
+2,788
+2% +$1.33M 0.38% 62
2020
Q4
$79.3M Buy
170,203
+1,836
+1% +$861K 0.38% 57
2020
Q3
$74.3M Buy
168,367
+3,628
+2% +$1.5M 0.42% 54
2020
Q2
$59.7M Buy
164,739
+2,633
+2% +$883K 0.38% 60
2020
Q1
$46M Buy
162,106
+4,101
+3% +$1.29M 0.36% 64
2019
Q4
$51.3M Buy
158,005
+7,308
+5% +$2.22M 0.34% 66
2019
Q3
$43.9M Buy
150,697
+11,457
+8% +$3.28M 0.32% 76
2019
Q2
$40.9M Buy
139,240
+3,906
+3% +$1.08M 0.31% 74
2019
Q1
$37M Buy
135,334
+11,350
+9% +$2.82M 0.3% 76
2018
Q4
$27.7M Buy
123,984
+9,862
+9% +$2.31M 0.27% 90
2018
Q3
$27.9M Buy
114,122
+6,493
+6% +$1.49M 0.24% 96
2018
Q2
$22.3M Buy
107,629
+7,796
+8% +$1.65M 0.21% 101
2018
Q1
$20.6M Buy
99,833
+31,384
+46% +$6.59M 0.21% 108
2017
Q4
$13M Buy
68,449
+5,573
+9% +$1.07M 0.14% 179
2017
Q3
$11.9M Buy
62,876
+4,767
+8% +$863K 0.14% 173
2017
Q2
$10.1M Sell
58,109
-3,468
-6% -$583K 0.13% 195
2017
Q1
$9.46M Buy
61,577
+47
+0.1% +$7.18K 0.13% 196
2016
Q4
$8.68M Buy
61,530
+4,401
+8% +$649K 0.13% 191
2016
Q3
$9.09M Sell
57,129
-57,453
-50% -$8.85M 0.16% 152
2016
Q2
$16.9M Buy
114,582
+63,066
+122% +$9.31M 0.35% 72
2016
Q1
$7.29M Sell
51,516
-413
-0.8% -$55.3K 0.19% 129
2015
Q4
$7.37M Sell
51,929
-1,118
-2% -$149K 0.19% 134
2015
Q3
$6.49M Buy
53,047
+1,728
+3% +$225K 0.18% 137
2015
Q2
$6.66M Buy
51,319
+2,116
+4% +$276K 0.14% 178
2015
Q1
$6.61M Buy
49,203
+6,774
+16% +$873K 0.12% 205
2014
Q4
$5.32M Sell
42,429
-4,272
-9% -$519K 0.11% 233
2014
Q3
$5.68M Buy
46,701
+17,664
+61% +$2.15M 0.12% 212
2014
Q2
$3.43M Sell
29,037
-2,899
-9% -$341K 0.07% 335
2014
Q1
$3.84M Buy
31,936
+4,986
+19% +$593K 0.09% 271
2013
Q4
$3M Buy
26,950
+20,435
+314% +$2.03M 0.08% 307
2013
Q3
$600K Buy
+6,515
New +$589K 0.02% 895

Other funds holding TMO

Janney Montgomery Scott's TMO Position: Q1 2026 in Review

Janney Montgomery Scott increased its Thermo Fisher Scientific (TMO) stake by 14% in Q1 2026, buying an estimated $7.64M and bringing the position to 116,856 shares worth $57.4M. The position accounts for 0.14% of the portfolio, ranked #150.

Janney Montgomery Scott first reported a position in TMO in Q3 2013 and has held it in 51 quarters since. The position peaked at $121M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Janney Montgomery Scott held 116,856 shares of Thermo Fisher Scientific worth $57.4M as of Q1 2026.
  • Janney Montgomery Scott bought 14,086 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.64M.
  • Thermo Fisher Scientific made up 0.14% of Janney Montgomery Scott's portfolio in Q1 2026, its #150 holding.
  • Janney Montgomery Scott first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 51 quarters since.
  • Janney Montgomery Scott's Thermo Fisher Scientific position peaked at $121M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.